Tango Pharma - TNGX Market Capitalization

Tango Therapeutics (TNGX) operates in an environment of fierce competition for clinical trial participants, where the risk of development obsolescence is extremely high. The company is betting on AI-driven target discovery systems and small molecule creation, investing heavily in science. The current metric stands at 4.34. This price chart on GURU.Markets complements the data regarding the pipeline of CRISPR-based precision medicines for solid tumors.

TNGX (Tango Therapeutics, Inc.) Market Capitalization history from 07/04/2022 to 11/12/2026

Tango Therapeutics Corp - analytical breakdowns and key metrics (TNGX)

- market price and analyst price targets:

Price Chart Tango Therapeutics, Inc.|TNGX - Broker Consensus Forecast

- issuer market value details:

Market Capitalization Tango Therapeutics Corp|TNGX - Full Takeover Company Value

- issuer book value statistics:

Accounting Value per Share Tango Therapeutics|TNGX - Accounting Capitalization|Market Value to Book Value Ratio tangotx.com|TNGX - Company Assets

- debt and liquidity details:

- net income and valuation multiples indicators:

TNGX - Company Net Income|Projected Future Earnings Tango Therapeutics|TNGX - Market Cap to Net Income Ratio|Projected Price to Earnings Tango Pharma|TNGX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Tango Therapeutics Corp|TNGX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Tango Therapeutics|TNGX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months tangotx.com|TNGX - Net earnings per share growth this year|Net earnings per share growth forecast for next year Tango Therapeutics

Analysis of all company metrics:TNGX (Tango Therapeutics, Inc.)

Original product of Tango Therapeutics Corp

Tango Therapeutics (TNGX) is developing innovative oncology therapies within the secure jurisdiction of the US, which minimizes external risks and stabilizes asset valuations. Market capitalization, calculated as the product of the current share price and the total number of outstanding shares, reflects the aggregate market consensus on the business's value, allowing investors to use the company's market value to determine the asset's degree of overbought status and avoid entering at historical highs.

Competitor analysis